Carlo Bernasconi

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Miguel Á. Sanz, Giuseppe Avvisati, Consuelo Rayón et al. · PubMed · 2000 · 632 citations

Medicine, Oncology, Pharmacology +17

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

Franco Mandelli, Daniela Diverio, Giuseppe Avvisati et al. · PubMed · 1997 · 474 citations

Medicine, Oncology, Pharmacology +10

Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.

Mario Lazzarino, Ester Orlandi, Marco Paulli et al. · Journal of Clinical Oncology · 1997 · 176 citations

Medicine, Oncology, Chemotherapy +13

Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues.

Ruth Chiquet‐Ehrismann, Yoichiro Matsuoka, Urs Hofer et al. · Cell Regulation · 1991 · 162 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases

Alessandrino Ep, Paolo Bernasconi, Daniela Caldera et al. · Bone Marrow Transplantation · 1999 · 140 citations

Medicine, Hematology, Oncology +15